Plain-English translation of NCT06992258 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Colorectal Cancer research guide โPhase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether combining with TAS-102 (also called Lonsurf) works better than alone for people with advanced colorectal cancer that has progressed despite standard treatments. About 120 patients will be randomly assigned to receive either the combination of both medications or alone. The goal is to see which approach helps patients live longer and control their cancer better.
Many patients with advanced colorectal cancer eventually stop responding to all standard treatments, leaving them with very limited options. This trial is exploring whether combining two different medications might offer better results than using just one, potentially giving patients with this difficult-to-treat cancer a more effective choice.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will be randomly assigned to take either the two-medication combination or the single medication. You will take these pills by mouth according to a set schedule. You'll need to visit the clinic regularly for blood tests, physical exams, and imaging scans to check how well the treatment is working and to watch for side effects. The study will continue until your cancer progresses, you experience unmanageable side effects, or you choose to stop.
AI-generated summary from trial data ยท Nov 17, 2026 ยท Not medical advice
United States